Differential hRad17 expression by histologic subtype of ovarian cancer
<p>Abstract</p> <p>Background</p> <p>In the search for unique ovarian cancer biomarkers, ovarian specific cDNA microarray analysis identified hRad17, a cell cycle checkpoint protein, as over-expressed in ovarian cancer. The aim of this study was to validate this express...
Main Authors: | Young Jennifer L, Koon E Colin, Kwong Joseph, Welch William R, Muto Michael G, Berkowitz Ross S, Mok Samuel C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | Journal of Ovarian Research |
Online Access: | http://www.ovarianresearch.com/content/4/1/6 |
Similar Items
-
Relationship of an hRAD54 gene polymorphism (2290 C/T) in an Ecuadorian population with chronic myelogenous leukemia
by: César Paz-y-Miño, et al.
Published: (2010-01-01) -
"Tegan c.c.c.” and “Hrad Technika.” HBS Cases 609-038 and 609-039
by: Upton, D
Published: (2009) -
Characterization of rare histological subtypes of ovarian cancer based on molecular profiling
by: Nobutaka Takahashi, et al.
Published: (2023-01-01) -
The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer
by: Juan Zhou, et al.
Published: (2018-12-01) -
Ovarian cancer risk factors by histologic subtype: an analysis from the Ovarian Cancer Cohort Consortium
by: Wentzensen, N, et al.
Published: (2016)